Hpv Negative Squamous Cell Carcinoma clinical trials

Explore recruiting hpv negative squamous cell carcinoma clinical trials.

Recruiting hpv negative squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hpv Negative Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck.

France, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Hpv Negative Squamous Cell Carcinoma trials by city

Hpv Negative Squamous Cell Carcinoma clinical trials

Recruiting hpv negative squamous cell carcinoma studies right now

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC

Also recruiting in Europe

A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck.

Hpv Negative Squamous Cell Carcinoma trials by city

Other conditions